Cargando…
Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs)
The rise of coronavirus (COVID-19) cases worldwide has driven the need to discover and develop novel therapeutics with superior efficacy to treat this disease. This study aims to develop an innovative aerosolized nano-formulation of favipiravir (FPV) as an anti-viral agent against coronavirus infect...
Autores principales: | Tulbah, Alaa S., Lee, Wing-Hin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540419/ https://www.ncbi.nlm.nih.gov/pubmed/34681283 http://dx.doi.org/10.3390/ph14101059 |
Ejemplares similares
-
In vitro bio-characterization of solid lipid nanoparticles of favipiravir in A549 human lung epithelial cancer cells
por: Tulbah, Alaa S.
Publicado: (2023) -
Effect of Palm or Coconut Solid Lipid Nanoparticles (SLNs) on Growth of Lactobacillus plantarum in Milk
por: Jo, Yeon-Ji, et al.
Publicado: (2015) -
Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
por: Mehrdadi, Soheil
Publicado: (2023) -
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
por: Satapathy, Mantosh Kumar, et al.
Publicado: (2021) -
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations
por: Mura, Paola, et al.
Publicado: (2021)